Home › Multiple Sclerosis
Pag-aaral pangklinika para sa Multiple Sclerosis na nagre-recruit sa U.S.
132 pag-aaral para sa Multiple Sclerosis ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY17 pag-aaral
- Chicago, IL15 pag-aaral
- Boston, MA14 pag-aaral
- Washington, DC13 pag-aaral
- Cleveland, OH9 pag-aaral
- St. Louis, MO8 pag-aaral
- Kansas City, KS8 pag-aaral
- Birmingham, AL8 pag-aaral
- San Francisco, CA8 pag-aaral
- Seattle, WA7 pag-aaral
- Columbus, OH7 pag-aaral
- Baltimore, MD7 pag-aaral
- Aurora, CO7 pag-aaral
- Farmington Hills, MI6 pag-aaral
- Milwaukee, WI6 pag-aaral
- Houston, TX6 pag-aaral
- Dallas, TX6 pag-aaral
- San Diego, CA5 pag-aaral
- Tampa, FL5 pag-aaral
- Austin, TX5 pag-aaral
- Atlanta, GA5 pag-aaral
- Durham, NC4 pag-aaral
- Brockton, MA4 pag-aaral
- New Haven, CT4 pag-aaral
- Knoxville, TN4 pag-aaral
- Naples, FL4 pag-aaral
- Champaign, IL4 pag-aaral
- Miami, FL4 pag-aaral
- Ann Arbor, MI4 pag-aaral
- Cincinnati, OH3 pag-aaral
- Rochester, MN3 pag-aaral
- Buffalo, NY3 pag-aaral
- Philadelphia, PA3 pag-aaral
- Mountain View, CA3 pag-aaral
- Kirkland, WA3 pag-aaral
- Scottsdale, AZ3 pag-aaral
- Palm Coast, FL3 pag-aaral
- Sandy Springs, GA3 pag-aaral
- Raleigh, NC3 pag-aaral
- Plano, TX3 pag-aaral
Ayos sa estado
- Alabama8 pag-aaral
- Arizona5 pag-aaral
- California24 pag-aaral
- Colorado11 pag-aaral
- Connecticut6 pag-aaral
- District of Columbia4 pag-aaral
- Florida13 pag-aaral
- Georgia7 pag-aaral
- Hawaii3 pag-aaral
- Illinois19 pag-aaral
- Kansas9 pag-aaral
- Kentucky3 pag-aaral
- Maryland17 pag-aaral
- Massachusetts18 pag-aaral
- Michigan10 pag-aaral
- Minnesota4 pag-aaral
- Missouri8 pag-aaral
- Nebraska3 pag-aaral
- New Jersey11 pag-aaral
- New York19 pag-aaral
- North Carolina8 pag-aaral
- Ohio14 pag-aaral
- Oklahoma3 pag-aaral
- Pennsylvania7 pag-aaral
- Tennessee6 pag-aaral
- Texas17 pag-aaral
- Utah3 pag-aaral
- Virginia3 pag-aaral
- Washington11 pag-aaral
- Wisconsin7 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Vancomycin Study in Multiple Sclerosis (MS)
Nagre-recruitPhase 1
Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05539729Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple Sclerosis
Nagre-recruit
Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07475377A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07840326A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06433752Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT03816345Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
1 Month – 99 Years · Lahat ng kasarian · Na-update Set 22, 2026 · NCT00794352Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
Nagre-recruitPhase 1/2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07477639A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)
Nagre-recruitObservasyonal na pag-aaral
Edad 15 hanggang 50 · Kababaihan · Na-update Set 21, 2026 · NCT06433765Delivery of a Culturally Tailored Exercise Training Intervention for Hispanics With Multiple Sclerosis
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07606742Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT00001248Clinical Applications of Advanced Ophthalmic Imaging
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT03135327Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
Nagre-recruitPhase 2
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT02784210Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation
Nagre-recruit
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT05958381Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Nagre-recruitPhase 3
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07325292RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07002034Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Nagre-recruitPhase 3
Edad 10 hanggang 17 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06408259A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06782490Exploring the Utility of [18F]3F4AP for Demyelination Imaging
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06999434A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06680037A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Nagre-recruitPhase 4
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07609719Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 120 · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT01730131Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain
Nagre-recruit
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07132775Identifying and Characterizing Preclinical MS
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT05787795Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
Nagre-recruitPhase 1/2
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT03109288An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
Nagre-recruitPhase 1
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT07224373Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.